Rockwell Medical Reports Third Quarter 2024 Earnings, Shows Profitability on Cash Flow and Adjusted EBITDA Basis for Second Straight QuarterWixom, Michigan – Rockwell Medical, Inc. (Nasdaq: RMTI), a global healthcare company focusing on the developme

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Rockwell Medical’s 8K filing here.

About Rockwell Medical

(Get Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

Featured Articles